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Abstract. A subset of cells, termed side-population (SP), 
which have the ability to efflux Hoeschst 33342, have previ-
ously been demonstrated to act as a potential method to 
isolate stem cells. Numerous stem/progenitor cells have been 
localized in different regions of the mouse hair follicle (HF). 
The present study identified a SP in the mouse HF expressing 
the ABCG2 transporter and MTS24 surface marker. These 
cells are restricted to the upper isthmus of the HF and have 
previously been described as progenitor cells. Consistent with 
their SP characteristic, they demonstrated elevated expression 
of ABCG2 transporter, which participates in the dye efflux. 
Analysis of tumor epidermal cell lines revealed a correlation 
between the number of SP keratinocytes and the grade of 
malignancy, suggesting that the SP may play a role in malig-
nant progression. Consistent with this idea, the present study 
observed an increased number of cells expressing ABCG2 and 
MTS24 in chemically induced skin tumors and skin tumor 
cell lines. This SP does not express the CD34 surface marker 
detected in the multipotent stem cells of the bulge region of 
the HF, which have been defined as tumor initiation cells. The 
present study concluded that a SP with properties of progenitor 
cells is localized in the upper isthmus of the HF and is impor-
tant in mouse skin tumor progression.
Introduction
A subset of cells, termed the side-population (SP), with 
characteristics of adult stem cells were discovered in hema-
topoietic tissue (1,2). Similarly, other side-populations have 
been identified in tissues, tumors and cell lines (3-5). The main 
feature of these SPs is their high efflux capability of antimi-
totic drugs. This characteristic allows the isolation of the SP 
based on their capacity to efflux the Hoechst 33342 dye (1,2). 
The membrane transporter breast-cancer-resistance-protein 
(BCRP1/ABCG2), which belongs to the multidrug resis-
tance protein family, is responsible for the efflux of Hoechst 
33342 (6). In agreement with their high efflux capacity, high 
expression of the BCRP1/ABCG2 was observed in the SP 
from hematopoietic lineage (7). Functional studies in the 
bone marrow, suggest that the ability to efflux Hoechst 33342 
may represent a universal stem cell trait. Remarkably, the 
SP has characteristics of adult stem cells such as long-term 
repopulating capacity, undifferentiated phenotype, and colony 
forming potential (1,2).
The skin is a multi-layered organ formed by the epidermis, 
dermis, hair follicles, sebaceous glands and subcutaneous 
tissue. In particular, the epidermis undergoes continual 
renewal, and their regenerative capacity is conferred by stem 
and progenitor cells located in the interfollicular epidermis and 
hair follicle (8-13). Other groups have previously investigated 
the existence of a SP in human and mouse epidermis (4,14-18). 
However, contradictories results have been reported in regard 
to their stem cell features, anatomic localization, and expres-
sion of surface markers. The discrepancies observed in the 
phenotype and behavior of epidermal SPs seem to be related to 
the cell isolation methodology, the Hoechst staining techniques 
and the anatomical origin of the epidermal cells. Numerous 
stem/progenitor cells have been localized in different 
regions of the skin such as in the interfollicular epidermis, 
sebaceous glands and hair follicle; however, whether any of 
these stem/progenitor cells behave as a side population is 
unknown. Herein, we present evidence demonstrating that a 
subset of cells expressing the MTS24/Plet1 surface marker can 
be isolated as a SP from the mouse hair follicle. These cells 
were located in the upper isthmus of the mouse hair follicle. 
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Importantly, a follicular keratinocyte cell population with 
characteristics of progenitor cells was previously localized in 
this region of the hair follicle (13,19). Consistent with their SP 
characteristics, we determined that these cells show elevated 
expression of the ABCG2 transporter and co‑localizes with 
the MTS24 marker suggesting that the ABCG2 transporter 
can be used as a marker of the hair follicle SP. Moreover, this 
SP does not express CD34 and keratin 15 (K15) which are 
characteristic of the multipotent stem cells of the bulge region 
of the hair follicle (BuSCs).
Early reports have shown that BuSCs partially overlap with 
label-retaining cells (LRCs), previously described as tumor 
initiating cells (8,20-22). However, it is not clear whether 
other hair-follicle progenitor cells play a role as skin tumor 
initiating cells. We sought to study whether the hair follicle 
SP is involved in skin tumor progression. We observed kera-
tinocytes expressing MTS24 and the ABCG2 transporter on 
the proliferative basal cell layer of mouse skin papillomas. 
Importantly, immunostaining analysis of chemically induced 
skin tumors showed an increased number of cells expressing 
MTS24 and ABCG2 in malignant regions of mouse skin 
tumors. Furthermore, we established a direct correlation 
between the size of the SP and the rate of malignancy in 
tumor cell lines derived from mouse skin tumors, suggesting 
that the SP plays a role in malignant progression. Consistent 
with these results, the SPs have been identified in numerous 
cancer cell lines, as important contributors to tumor mainte-
nance and tumorigenic potential (23-26). We conclude that 
ABCG2+/MTS24+ cells identified a SP localized in the upper 
isthmus of the hair follicle. In addition, histopathological 
analysis of skin papillomas suggest that this SP may play a 
role in skin tumor progression.
Materials and methods
Mouse models. All animal experiments were approved by 
the NC State University Institutional Animal Care and Use 
Committee (IACUC). FVB/NCrl mice were obtained from 
Charles River laboratories (strain 207) and K15EGFP mice 
from The Jackson Laboratory (B6.Cg‑Tg [Krt1‑15‑EGFP] 
2Cot/J, Stock number 005244).
Skin papillomas were induced in transgenic mice overex-
pressing CDK4 in the epidermis (K5CDK4) by the two‑stage 
carcinogenesis protocol as we previously described (27,28). 
Briefly, groups of 20 mice each (K5CDK4 and wild type 
siblings) were initiated at day 1 after birth by topical applica-
tion of 50 mg of DMBA in 50 ml of acetone on the mouse back. 
At day 14, mice received 2.5 mg of TPA in 200 ml of acetone 
twice a week for 20 weeks. Skin papillomas were collected at 
the end of the experiment at 30 weeks. Immunohistochemical 
analysis of skin tumors was performed on paraffin‑embedded 
sections from mouse skin papillomas as described below.
Identification of side population. We used a method developed 
by Goodell et al for the identification of side population of 
mouse keratinocytes (2). Mouse keratinocytes from the hair 
follicle were isolated after disposal interfollicular keratino-
cytes as we previously reported (29). Briefly, dorsal skins from 
7-week old mice were pooled and disassociated into single 
cells by incubating in 0.25% trypsin for 5 min at 37˚C. Cells 
were washed and suspended at 1x106 cells/ml in PBS with 
2% fetal bovine serum and further incubated with Hoechst 
33342 dye (Sigma, St. Louis) at 5 µg/ml with or without a 
100 µM verapamil for 90 min at 37˚C. Cells were centrifuged, 
washed, and suspended in PBS/2% fetal bovine serum and 
2 µg/ml of Propidium iodide (PI). Flow cytometric analysis 
was conducted using a DAKO Cytomation MoFlo Ultra‑High 
Speed Cell Sorter. Hoechst dye was excited with a UV laser set 
at 350 nm and its fluorescence measured using a 450/20-nm 
(Hoechst blue) band‑pass filter and a 670 filter (Hoechst red). 
Cells were analyzed and sorted within PI-negative cells, which 
represents a living population. The side-population gate was 
chosen by a direct comparison against the verapamil-treated 
cells. Three independent replication of this experiment 
confirms the percentage of SP in the mouse hair follicle.
CH72, JWF2, C50 and 308 cell lines were cultivated on 
EMEM (Cambrex, #06‑174 G) + 1% chelex FBS, whereas 
Balb/MK2 cells were incubated on EMEM + 8% chelex FBS. 
Cells were suspended by trypsination, washed and suspended 
on PBS (without Ca2+ and Mg2+). Side population's analyses 
were conducted by FACS analysis as described for mouse 
keratinocytes.
Reverse transcription‑PCR of SP and non‑SP keratinocytes. 
SP and non-SP cells were sorted into microcentrifuge tubes, 
and total RNA extracted using a RNeasy Kit (Id 74134, Qiagen, 
Germantown, MD). Thirty ng of total RNA were used for 
first‑strand cDNA synthesis in the reverse transcription‑PCR 
(RT‑PCR) mixture: 4 µl of 5X first strand buffer, 1 µl of 
0.1 mol/L DTT, 1 µl of RNaseOUT RNase inhibitor, 1 µl of 
random hexamer primers (50 µm), 1 µl of 10 mmol/l deoxynu-
cleotide triphosphate mix, and 1 µl of SuperScript III reverse 
transcriptase and brought to 20 µl with RNase‑free water. The 
reverse transcriptase mixture was incubated at 65˚C for 5 min, 
25˚C for 5 min, 50˚C for 60 min, and 70˚C for 15 min. q‑PCR 
was conducted using 1.5 µl of the reverse transcription reac-
tion and SYBR Green Supermix (Bio‑Rad, Hercules, CA). The 
reference gene glyceraldehyde‑3‑phosphate dehydrogenase 
(GAPDH) was used to normalize the Ct values of the genes 
of interest (ΔCt). Relative alterations (fold change) in mRNA 
expression levels in SP and non‑SP were calculated according 
to the algorithms 2- (ΔΔCt). FACS isolation was performed in 
duplicate, and each qRT‑PCR reaction was performed in trip-
licate. PRIMERS: CD34 (F: agg ctc tgg aac tcc aca cac ttt, R: taa 
gca tat ggc tcg gtg ggt gat), α6 integrin (F: agc ccc agg gac tta caa ct, 
R: ctc ttg gag cac cag aca ca), ABCG2 (F: cca tag cca cag gcc aaa, R: 
ggg cca cat gat tct tcc ac), Lrig1 (F: acc att tca ctc cag gca ac, R: gtg 
aag atg cct acg gtg gt), Lgr6 (F: agg tgt cag aag ctg gag ga, R: tca gct 
ggt tgt cag tca gg), Keratin 15 [K15] (F: gga ggt gga agc cga agt at, 
R: gag agg aga cca cca tcg cc), CD71 (F: tcg ctt ata ttg ggc aga cc, R: 
cca tgt ttt gac caa tgc tg), GAPDH (F: gca aag tgg aca ttg tcg cca tca, 
R: tcc tgg aag atg gtg atg gcc ttt).
Immunostaining. Murine dorsal skins were embedded in OCT 
compound (Tissue‑Tek; American Master Tech Scientific), 
frozen, and sectioned following standard protocols. Sections 
were blocked with 10% normal serum, and stained with 
antibodies for anti‑CD34 (BD Biosciences, Pharmingen, San 
Jose, CA), anti-BCRP1/ABCG2 (ab24115, Abcam, Cambridge, 
MA) and anti-MTS24/Plet-1 (sc-240781, Santa Cruz Biotech.) 
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followed by incubation with Alexafluor secondary antibodies 
(FITC re‑conjugated anti‑Rat or anti‑goat; ThermoFisher, 
Molecular probes, Waltham, MA). Frozen cross‑sections were 
counterstained with 4'6'‑diamidino‑2‑phenylindole (DAPI) 
and visualized under a fluorescence microscope using a 465 
to 495 nm filter. Paraffin-embedded sections from mouse 
skin papillomas were immunostained with anti-MTS24 and 
anti-ABCG2 antibodies described above. The number of 
MTS24+ and ABCG2+ cells were determined in sections of 
250 µm2 with a reticular grid.
Statistical analysis. Statistical analysis was performed using 
GraphPad Prism 4 Software (GraphPad Software, San Diego, 
CA, USA).
Results
Mouse hair follicles harbors a side‑population of keratino-
cytes expressing the cell‑surface marker MTS24. Numerous 
stem/progenitor cells have been localized in different regions 
of the mouse hair follicle (9,13,30,31); however, whether 
any of these cells behave as a SP remains to be elucidated. 
Therefore, we first sought to localize and characterize a SP 
in the mouse hair follicle. Mouse keratinocytes from the hair 
follicle (HF‑keratinocytes) were isolated after disposal of the 
interfollicular keratinocytes as we previously described (29).
HF‑keratinocytes were incubated with Hoechst 33342 
or Hoechst 33342 + 100 µM verapamil. The addition of 
verapamil, which blocks the ABCG2 transporter, resulted 
in the reduction of the SP to background levels as deter-
mined via flow cytometry analysis (data not-shown) (29). 
We observed that 1.8% of the HF‑keratinocytes actively 
effluxed the Hoechst 33342 dye and showed that 85% of the 
hair follicle SP were MTS24-positive (Fig. 1A and B). This 
outcome is consistent with a previous finding showing that a 
MTS24-positive progenitors located between the sebaceous 
glands and the hair follicle bulge (19). To further confirm the 
SP nature of the MTS24+ cells, we investigated the expres-
sion of the ABCG2 transporter. Real-time PCR analysis of 
the SP and non-SP fractions described in the fig. 1A revealed 
2.5‑fold elevated expression of the ABCG2 transporter in SP, 
supporting the high efflux of Hoechst 33342 by the SP fraction 
(Fig. 1C). Different populations of hair follicle stem/progeni-
tors were characterized for the expression of surface markers 
such as CD34, MTS24, Lrg1, Lgr6, α6-integrin and keratin 
15 (K15) (19,32-37). To establish the relationship of the hair 
follicle SP to the previously described stem/progenitors 
keratinocytes, we set out to determine the expression of the 
stem cell markers keratin 15, integrin α6 and the cell-surface 
markers CD34, Lrig1, Lgr6, CD71 via qRT‑PCR. We observed 
a reduced level of CD34 and keratin 15 in the SP confirming 
that these cells are different from the CD34+/K15+ multi-
potent stem cells localized in the bulge region of the hair 
follicle (15,19,34). Moreover, we determine that the expression 
level of Lrig1 and Lgr6 markers, which define progenitor 
cell populations restricted to the junctional zone (35) and the 
central isthmus of the hair follicle (36), was also low in the SP 
(Fig. 1C). We conclude that the hair follicle SP is composed 
of MTS24-positive progenitors, which are different from 
the Lrg1‑, Lgr6‑ and CD34‑positive stem/progenitors cells. 
Similar levels of expression of the integrin α6 confirm the 
keratinocyte nature of both, SP and non-SP.
To further elucidate whether the hair follicle SP is restricted 
to a specific area of the hair follicle, we performed immunofluo-
rescence analysis to localize the ABCG2 and MTS24 proteins in 
the mouse hair follicle (Fig. 2). We utilized the dorsal skin from 
7‑weeks old K15‑EGFP transgenic mice, which expresses the 
green fluorescent protein (EGFP) under the control of the keratin 
15 promoter in the bulge area of the hair follicle (32). Bright 
staining of MTS24 was predominantly found within a region 
between the bulge and the sebaceous gland (Fig. 2A and E). 
Notably, this region was also positive for the ABCG2 transporter 
(Fig. 2F). Overlapping image of MTS24 and ABCG2 immuno-
fluorescence showed that both proteins are express in the upper 
isthmus of the hair follicle (Fig. 2G, yellow color). These results 
are consistent with the previous localization of MTS24+ kerati-
nocytes (19). EGFP staining labeled keratinocytes expressing 
K15 in the bulge area of the hair follicle (Fig. 2B). Overlapping 
image of MTS24 and EGFP immunostaining confirm that the 
hair follicle side‑population and K15/CD34+ cells are different 
stem/progenitor cells (Fig. 2C).
Increase size of epidermal side‑populations skin tumor and 
tumor cell lines. Consistent with the high efflux capability 
to Hoechst 33342, the ABCG2 transporter has been identi-
fied as a candidate protein responsible for cancer multidrug 
resistance. In fact, the ABCG2 gene encodes the breast cancer 
resistance protein (BCRP1) which is expressed in colon, 
breast, stomach and fibrosarcoma cell lines (38,39). This data 
suggests that the tumor SPs play an important role in tumor 
resistance to chemotherapeutic treatments. Importantly, the 
SP has been found on numerous cancer cell lines, and cells 
derived from primary tumors (23,25,26). Herein, we studied 
the presence of the SP in skin tumor cell lines. We utilized a 
set of cell lines derived from mouse skin keratinocytes (C50 
and Balb/MK2), chemically initiated skin keratinocytes [308 
cell line, (40)], and squamous‑cell carcinomas (SCC) [JWF2 
and CH72, (41,42)]. Therefore, this model allows direct 
comparison between the SPs isolated from different stages 
of tumor progression. We evaluated the percentage of SP in 
each cell line by Hoechst 33342 dye exclusion. Incubation of 
each cell line in the presence of verapamil resulted in limited 
detection of the SP to a background level, indicating that dye 
efflux occurs through the ABC transporters. We use verapamil 
treatment as a mean to define the presence of the SPs. Cell 
cultures from non-tumorigenic keratinocytes (C50, Balb/Mk2) 
and cells derived from initiated skin (308) showed a low rate 
of SP. The percentage of cells isolated as SPs in the Balb/Mk2 
(0.1%), C50 (0.2%) and 308 (0.3%) cell lines were similar 
to the percentage originally observed in the hematopoietic 
system (1). In contrast, we detected an increased percentage 
of SPs in the JWF2 (4.7%) and CH72 (4.3%) cell lines, which 
showed 15-fold rise in the number of SP cells compared with 
the 308 cells (t‑test, P<0.0001) (Fig. 3). Our results show a direct 
correlation between the increase number of progenitor/stem 
cells determined by the SP technique and the ability of these 
cells to drive malignant progression in mouse epidermis. To 
the best of our knowledge, this is the first time that a direct 
comparison between SPs was performed on cell lines derived 
from different stages of the tumor progression.
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To determine whether the increase percentage of the 
SPs observed in keratinocyte cell lines denote what occur 
during mouse skin carcinogenesis, we examine a series 
of chemically initiated mouse skin papilloma. We evalu-
ated tumor cells expressing the ABCG2 transporter and the 
cell surface marker MTS24 on mouse skin papillomas in 
which transgenic expression of the cyclin dependent kinase 
4 in the skin (K5CDK4 transgenic mice) resulted in early 
premalignant changes (27,43). The ABCG2 transporter and 
MTS24 surface marker were expressed in clusters of cells on 
the proliferative basal cell layer of skin papillomas (Fig. 4). 
Skin papillomas from transgenic K5CDK4 mice at 30 weeks 
of promotion, presented areas of marked atypia and lack of 
differentiation pattern (intra-papilloma carcinoma and carci-
noma in situ) (27). Remarkable, we observed an increased 
number of cells expressing ABCG2 and MTS24 in papillomas 
Figure 2. Expression of ABCG2 transporter and MTS24 surface marker in the mouse hair follicle (HF). Dorsal skin cryosections were labeled with antibodies 
against (A and E) the cell surface marker MTS24 (arrows) and (F) the ABCG2 transporter (arrows). (B) Enhance green fluorescent protein (EGFP) show cells 
expressing the keratin 15 (K15) in the transgenic mice K15EGFP (arrow). (C) Overlapping immunofluorescence of panels A and B reveals that MTS24 does 
no colocalize with the HF bulge marker K15, (G) whereas overlapping image of panels E and F shows that MTS24 and ABCG2 colocalize in the isthmus area 
of the HF. SG, sebaceous gland; Bu, bulge region of the HF; *Auto fluorescence (hair shaft). DAPI counter stain (D).
Figure 1. The side‑population from the mouse hair follicle. (A) Hoechst 33342 staining of the mouse hair follicle epidermal cell suspension reveals that 
1.8% of total HF keratinocytes excluded Hoechst and was defined as a SP. Three independent replication of this experiment confirms the percentage of SP 
in the mouse hair follicle. (B) Staining with anti‑MTS24/Plet1 antibody shows that 85% of the SP express the MTS24 surface marker. (C) Expression of hair 
follicle stem/progenitor markers was determined by qRT‑PCR. 2-ΔΔCT values from SP and non‑SP were quantified with specific primers for CD34, α6 integrin, 
ABCG2/BCRP1, LRIG1, Lgr6, keratin 15 (K15), and CD71. The reference gene GAPDH was used to normalize the Ct value of the genes of interest. The cell 
fraction enriched in each marker was calculated as the ratio of SP/non‑SP. Values >1 represents higher expression in SP, whereas values <1, represent a higher 
expression in non‑SP.
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of the K5CDK4 transgenic mouse. Whereas wild‑type tumors 
showed 12 cells per clusters expressing ABCG2 and MTS24, 
papillomas from K5CDK4 transgenic mice showed ~50 cells 
per clusters expressing the SP markers (P<0.05, t‑test) 
(Fig. 4E). Altogether, these results suggest that the increased 
size of the SP may play a functional role during the skin tumor 
progression or, alternatively, the increased number of SP cells 
may contribute to the maintenance of the malignant pheno-
type (44-46).
Discussion
The existence of SP has been determined in many tumors and 
tissues, including the epidermis. However, the functional role 
of epidermal SP remains ambiguous. Some early investiga-
tions suggested that the SP in mouse epidermis lacks the stem 
cell characteristics (16,47,48), whereas other groups reported 
opposite results (4,15). For instance, it has been suggested that 
the mouse epidermal SPs lack the stem cell features, because 
the majority of the label‑retaining cells, which are considered 
multipotent stem cells, are found in the non-SP fraction (47). 
On contrary, it was reported that epidermal SPs behave as 
keratinocyte stem cells due of their higher expression of the β1, 
α6 integrins (4) exhibiting phenotypic and functional features 
of stem cells (15). These discrepancies might be due to cell 
isolation methodology or more importantly to the cellular 
origin of the SPs.
Here, we described a SP isolated from the mouse hair 
follicle which is restricted to the upper isthmus, a region 
between the sebaceous gland and the bulge. These cells express 
the ABCG2 transporter, which supports its SP characteristics, 
and the MTS24 surface marker. Supporting a stem/progenitor 
role of this SP, Jensen et al described a keratinocyte population 
with characteristics of progenitors in the upper isthmus of the 
mouse HF (13). Other groups have reported the localization of 
a SP in the interfollicular region of the mouse epidermis. In 
agreement with the description of the HF side‑population, the 
interfollicular SPs of newborn and adult mice also showed an 
elevated expression of the ABCG2 transporter (4). Likely, the 
inconsistency in terms of the localization of the epidermal SP 
is due to cell isolation methodology. In fact, we isolated a SP 
from the mouse hair follicle, after disposal the interfollicular 
keratinocytes, whereas Yano et al make use of a full epidermal 
preparation (4,29). Therefore, it is possible that distinct SP may 
exist in different regions of the mouse epidermis or alternatively, 
the hair follicle SP may give origin to the interfollicular SP. We 
utilized the epidermis of 7‑days old mice in which the HF is 
in the rest phase of the hair cycle (telogen), but an observation 
generated during the course of this study shows that induction 
of anagen (proliferative phase of hair follicle cycle) by topical 
application of TPA result in detection of the MTS24+ cells in 
the interfollicular epidermis (unpublished data). Similarly, 
Trempus et al showed that MTS24+ cells are located in the 
interfollicular epidermis after topical treatment with TPA (34). 
Although, lineage studies are necessary to define the relation-
ship between hair follicle and interfollicular SPs, we cannot rule 
out the possibility that the hair follicle SP might give origin to 
the interfollicular SP in specific phases of the hair cycle or in 
pathologic conditions leading to mobilization of the HF kerati-
nocytes to the interfollicular epidermis. This model is supported 
for a recent publication showing that ABCG2 deficiency in skin 
impairs re-epithelialization in cutaneous wound-healing (49). 
Figure 3. Detection of side population (SP) in mouse epidermal cell lines. Hoechst 33342 staining of mouse cell lines reveals that a low number of SP cells in 
the epidermal cell lines Balb/MK2 (0.1%) and C50 (0.2%), and the papilloma cell line 308 (0.3%). A higher number of cells derived from the mouse epidermal 
squamous cell carcinomas showed the SP patter of staining (JWF2, 4.7%; and CH72, 4.3%) compared to epidermal cell lines (t‑test, P<0.0001). Verapamil 
treatment was used to determine the gated region of each cell lines. Example, CH72/verapamil.
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Therefore, it is conceivable that the ABCG2-positive SP plays 
an active role as progenitors during epidermal regeneration. 
Hence, the functional role of the hair follicle SP as progenitors 
of interfollicular epidermis warrant future investigations.
Notably, the anatomical localization of the epidermis might 
also influence the SP characteristics since SPs isolated from 
tail skin seem to be part of the transit amplifying, but not the 
progenitor compartment (47). On contrary, the hair follicle SP 
is composed by ABCG2+/MTS24+ cells, with characteristics 
of progenitor cells (19); although, they are different from the 
CD34+ bulge stem cells and the Lrig1+ and Lgr6+ progenitors. It 
worth mentioning that the MTS24+ keratinocytes are a hetero-
geneous population composed for cells with a variable amount 
of the integrin α6 (α6-low and α6-high) (13). Therefore, it 
remains to be determined whether both, α6-low and α6-high, 
keratinocytes form part of the SP. Moreover, our studies have 
shown that 85% of the SP express the MTS24 marker, leave 
open the possibility that MTS24‑negative cells can also efflux 
Hoeschst 33342 and behave as a SP.
Pioneer studies have established that the interfollicular and 
hair follicle bulge stem cells are carcinogen targets that give 
rise to latent neoplastic cells contributing to tumor develop-
ment (50-52). In agreement, it has been recently recognized that 
K15+ stem cells contribute to skin papilloma development (37). 
However, whether other hair follicle progenitor cells also 
contribute to tumor initiation need to be determined. In this 
regard, it is now known that HFs are home to many popula-
tions with stem cell properties, each with different markers and 
different locations within the follicle. Here, we have shown that 
similar to K15+/CD34+ bulge stem cells, ABCG2+/MTS24+ cells 
are located in specific areas of the mouse skin papillomas. In 
addition, we observed an increase number of ABCG2+/MTS24+ 
keratinocytes in premalignant skin papillomas suggesting that 
the epidermal tumor SPs might be composed for cancer stem 
cells (CSCs). This effect is different from the one reported for 
K15+ bulge stem cells which contribution to skin tumors does 
not appear to increase during the malignant progression (37). 
The concept of CSCs has generated much hope for cancer 
treatment because are thought that CSCs are resistant to chemo-
therapy and molecular therapies via their high expression of the 
multidrug resistance genes (53). Therefore, our data suggest that 
the epidermal tumor cells expressing ABCG2 and MTS24 may 
Figure 4. Immunofluorescence analysis of MTS24 and ABCG2 in skin papillomas. (A and C) Expression of the ABCG2 transporter and the MTS24 surface 
marker was detected in the basal cell layer of skin papillomas (arrows). (B and D) DAPI counter stain. (E) Increase number of ABCG2+ and MTS24+ cells were 
observed in premalignant areas of K5CDK4 papillomas compared to wild‑type (WT) tumors (P<0.05, t‑test).
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play an important role in tumor resistance to chemotherapeutic 
treatments. Therefore, identification of skin stem/progenitors 
cells such as the ABCG2+ cells will allow studying their specific 
role in tumor promotion and progression in cutaneous squamous 
cell carcinomas. Although the best of our knowledge a similar 
SP has not been characterized in human SCCs, utilizing the 
drug high efflux features of keratinocyte SP to isolated ABCG2+ 
cells in human SCC will allow to study their tumor resistance 
to chemotherapeutic treatments. This is especially important in 
high‑risk squamous cell carcinomas which represent a subgroup 
of this disease, where patients are at higher risk of metastasis 
and death (54). Moreover, isolation of stem/progenitor cells is of 
paramount importance as a source of epidermal renewal in vivo. 
We expect that future identification of the regulatory sequences 
of MTS24/Plet1 and ABCG2 genes will allow employ trans-
genic mouse technology to trace in intact follicles the lineage of 
the side population into differentiated epithelia and skin tumors.
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